ITTO20040224A1 - Procedimento in vitro per la diagnosi di malattie neoplastiche mediante analisi della metilazione del gene cdh4, oligonucleotidi e kit utili in tale procedimento - Google Patents

Procedimento in vitro per la diagnosi di malattie neoplastiche mediante analisi della metilazione del gene cdh4, oligonucleotidi e kit utili in tale procedimento

Info

Publication number: ITTO20040224A1
Authority: IT; Italy
Prior art keywords: procedure; cdh4; diagnosis; analysis; neoplastic diseases
Prior art date: 2004-04-09

Application number

IT000224A

Other languages

English (en)

Inventor

Elena Miotto

Massimo Negrini

Silvia Sabbioni

Original Assignee

Univ Ferrara

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-04-09

Filing date

2004-04-09

Publication date

2004-07-09

2004-04-09 Application filed by Univ Ferrara filed Critical Univ Ferrara

2004-04-09 Priority to IT000224A priority Critical patent/ITTO20040224A1/it

2004-07-09 Publication of ITTO20040224A1 publication Critical patent/ITTO20040224A1/it

2005-04-07 Priority to EP05102717A priority patent/EP1584629B1/en

2005-04-07 Priority to AT05102717T priority patent/ATE373013T1/de

2005-04-07 Priority to DE602005002390T priority patent/DE602005002390T2/de

Links

238000000034 method Methods 0.000 title abstract 4
238000003745 diagnosis Methods 0.000 title abstract 2
201000010099 disease Diseases 0.000 title abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
230000011987 methylation Effects 0.000 title abstract 2
238000007069 methylation reaction Methods 0.000 title abstract 2
230000001613 neoplastic effect Effects 0.000 title abstract 2
101100326581 Caenorhabditis elegans cdh-4 gene Proteins 0.000 title 1
108091034117 Oligonucleotide Proteins 0.000 title 1
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 title 1
238000000338 in vitro Methods 0.000 title 1
239000000523 sample Substances 0.000 abstract 2
101150005024 CDH4 gene Proteins 0.000 abstract 1
108091029523 CpG island Proteins 0.000 abstract 1
206010028980 Neoplasm Diseases 0.000 abstract 1
230000002489 hematologic effect Effects 0.000 abstract 1
108020004707 nucleic acids Proteins 0.000 abstract 1
150000007523 nucleic acids Chemical class 0.000 abstract 1
102000039446 nucleic acids Human genes 0.000 abstract 1
239000002773 nucleotide Substances 0.000 abstract 1
125000003729 nucleotide group Chemical group 0.000 abstract 1
239000013615 primer Substances 0.000 abstract 1
239000002987 primer (paints) Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays

Landscapes

Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Pathology (AREA)
Analytical Chemistry (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Physics & Mathematics (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Molecular Biology (AREA)
Hospice & Palliative Care (AREA)
Biophysics (AREA)
Oncology (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

IT000224A 2004-04-09 2004-04-09 Procedimento in vitro per la diagnosi di malattie neoplastiche mediante analisi della metilazione del gene cdh4, oligonucleotidi e kit utili in tale procedimento ITTO20040224A1 (it)

Priority Applications (4)

Application Number	Priority Date	Filing Date	Title
IT000224A ITTO20040224A1 (it)	2004-04-09	2004-04-09	Procedimento in vitro per la diagnosi di malattie neoplastiche mediante analisi della metilazione del gene cdh4, oligonucleotidi e kit utili in tale procedimento
EP05102717A EP1584629B1 (en)	2004-04-09	2005-04-07	An in vitro method for the diagnosis of neoplastic diseases by methylation analysis of the CDH4 gene, oligonucleotides and kits useful in such method
AT05102717T ATE373013T1 (de)	2004-04-09	2005-04-07	In vitro verfahren zur diagnose von neoplastischen erkrankungen durch analyse des methylierungsstatus des cdh4 gens, oligonukleotide und kits zur durchführung eines solchen verfahrens
DE602005002390T DE602005002390T2 (de)	2004-04-09	2005-04-07	In vitro Verfahren zur Diagnose von neoplastischen Erkrankungen durch Analyse des Methylierungsstatus des CDH4 Gens, Oligonukleotide und Kits zur Durchführung eines solchen Verfahrens

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT000224A ITTO20040224A1 (it)	2004-04-09	2004-04-09	Procedimento in vitro per la diagnosi di malattie neoplastiche mediante analisi della metilazione del gene cdh4, oligonucleotidi e kit utili in tale procedimento

Publications (1)

Publication Number	Publication Date
ITTO20040224A1 true ITTO20040224A1 (it)	2004-07-09

Family

ID=34897828

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IT000224A ITTO20040224A1 (it)	2004-04-09	2004-04-09	Procedimento in vitro per la diagnosi di malattie neoplastiche mediante analisi della metilazione del gene cdh4, oligonucleotidi e kit utili in tale procedimento

Country Status (4)

Country	Link
EP (1)	EP1584629B1 (it)
AT (1)	ATE373013T1 (it)
DE (1)	DE602005002390T2 (it)
IT (1)	ITTO20040224A1 (it)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN115651980A (zh) *	2022-05-31	2023-01-31	益善生物技术股份有限公司	人rnf180基因甲基化检测试剂盒和提取待检测dna的方法

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2660218A1 (en)	2006-08-08	2008-02-14	Epigenomics Ag	A method for methylation analysis of nucleic acid

2004
- 2004-04-09 IT IT000224A patent/ITTO20040224A1/it unknown
2005
- 2005-04-07 EP EP05102717A patent/EP1584629B1/en not_active Expired - Lifetime
- 2005-04-07 DE DE602005002390T patent/DE602005002390T2/de not_active Expired - Lifetime
- 2005-04-07 AT AT05102717T patent/ATE373013T1/de not_active IP Right Cessation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN115651980A (zh) *	2022-05-31	2023-01-31	益善生物技术股份有限公司	人rnf180基因甲基化检测试剂盒和提取待检测dna的方法

Also Published As

Publication number	Publication date
DE602005002390T2 (de)	2008-06-05
ATE373013T1 (de)	2007-09-15
EP1584629B1 (en)	2007-09-12
DE602005002390D1 (de)	2007-10-25
EP1584629A1 (en)	2005-10-12

Similar Documents

Publication	Publication Date	Title
JP2021045140A (ja)	2021-03-25	Ｒｎａウイルスを検出するための組成物及び方法
WO2004011624A3 (en)	2004-12-09	Double stranded rna structures and constructs, and methods for generating and using the same
DK2357226T3 (da)	2012-06-25	Rationelt udformede meganukleaser med ændret sekvensspecificitet og DNA-bindingsaffinitet
CY1108730T1 (el)	2014-04-09	Θεραπεια ασθενειας hundington με epa
DE60142254D1 (de)	2010-07-08	Zusammensetzungen, methoden und reagentien zur nukleinsäureisolierung mittels oberflächenaktiven substanzen und proteasen
EP1630237A3 (en)	2006-03-15	Isolation of nucleic acid fragments by hybridisation to a solid support
IL190501A0 (en)	2008-11-03	Multicomponent nucleic acid enzymes and methods for their use
EE200200378A (et)	2003-10-15	Meetod patogeensete organismide liikidevahelisekseristamiseks ja meetod patogeensete organismide detekteerimiseks
DE60329853D1 (de)	2009-12-10	Verbesserte zusammensetzungen und verfahren für die cdna-synthese
PT1283907E (pt)	2005-01-31	Metodo para o diagnostico de cancros
AR067135A1 (es)	2009-09-30	Metodos para aislar arn de fragmento largo de muestras fijas
BRPI0517131A2 (pt)	2008-12-30	mÉtodos para simplificar Ácidos nuclÉicos microbiais por modificaÇço quÍmica de citosinas
WO2007035893A3 (en)	2009-04-30	Use of ivt with single stranded primer promoter selector constructs
ATE461294T1 (de)	2010-04-15	Brustkrebsdiagnoseverfahren
WO2007109733A3 (en)	2008-01-24	Diagnostic and prognostic markers and treatment strategies for multiple sclerosis
AR037870A1 (es)	2004-12-09	Metodo para determinar la actividad biologica de defibrotida
DE602005017252D1 (de)	2009-12-03	Verfahren zur amplifikation von nukleinsäuren mittels promotor-templates
DE602005022714D1 (de)	2010-09-16	Hybridisierung von pna-sonden in alkohollösungen
WO2005056839A3 (de)	2006-03-09	Primer und sonden zum nachweis genitaler hpv-genotypen
WO2006022619A3 (en)	2006-05-11	Methods for identifying risk of type ii diabetes and treatments thereof
AR056125A1 (es)	2007-09-19	Procedimiento para el diagnostico de tromboembolias y cardiopatias isquemicas
DE602005002390D1 (de)	2007-10-25	In vitro Verfahren zur Diagnose von neoplastischen Erkrankungen durch Analyse des Methylierungsstatus des CDH4 Gens, Oligonukleotide und Kits zur Durchführung eines solchen Verfahrens
AR014528A1 (es)	2001-02-28	Adn que comprende una secuencia de nucleotidos que se puede traducir a una proteina con actividad de invertasa, proteina derivada del adn que tieneactividad de invertasa pero que carece de actividad beta-fructofuranosidasa; metodo para producir adn y dicho metodo donde el adn es producido por una
WO2010123216A3 (ko)	2011-02-24	Cfh 또는 apoh를 급성골수성백혈병 관해 진단용 생화학적 마커로 사용하는 방법
WO2021195495A3 (en)	2021-11-25	Assays for detecting coronavirus disease 2019 (covid-19)